Martin Madaus, Ph.D.
Board Member
Repligen Corp (RGEN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Martin Madaus, Ph.D.
Martin Madaus, Ph.D. is recorded as Board Member at Repligen Corp (RGEN). Repligen Corp reported in an 8-K filed February 9, 2023 that Martin Madaus, Ph.D. was appointed Board of Directors, effective February 6, 2023.
“On February 6, 2023, based on the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Repligen Corporation (the “Company”), the Board elected Martin Madaus, Ph.D. to the Board, effective February 6, 2023 (the “Effective Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-02-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Repligen Corp
Other people whose current roles at this company are on record from its filings.
- Olivier Loeillot CEO, Board Member
- Dr. Martin D. Madaus Chairman, Board Member
- Martin D. Madaus Chairman
- Tony J. Hunt Chairman
- Jason Garland CFO
- Jason K. Garland CFO, Chief Accounting Officer
- James Bylund COO
- Violetta Hughes Chief Accounting Officer
- Carrie Eglinton Manner Board Member
- Glenn P. Muir Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.